Prolonging the Overall Survival by Vaccination of autologous tumor lysate-loaded dendritic Cells (DCVax-L) in Patients with newly diagnosed and recurrent Glioblastoma

被引：0
|
作者：
Deng, Maximilian Y. [1 ,2 ,3 ]
Debus, Juergen [1 ,2 ,3 ,4 ]
Koenig, Laila [1 ,2 ,3 ]
机构：
[1] Univ Klinikum Heidelberg, Klin Radioonkol & Strahlentherapie, Neuenheimer Feld 400, D-691201 Heidelberg, Germany
[2] Heidelberger Ionenstrahl Therapiezentrum HIT, Neuenheimer Feld 450, D-69120 Heidelberg, Germany
[3] Natl Ctr Tumorerkrankungen NCT Heidelberg, Neuenheimer Feld 460, D-69120 Heidelberg, Germany
[4] Deutsch Krebsforschungszentrum DKFZ, Klin Kooperationseinheit Strahlentherapie, Neuenheimer Feld 280, D-69120 Heidelberg, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2023年 / 199卷 / 03期
关键词：
RESPONSE ASSESSMENT; CRITERIA;
D O I：
10.1007/s00066-023-02049-x
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：327 / 329
页数：3
相关论文
共 50 条
  • [1] Autologous tumor lysate-loaded dendritic cell vaccination (DCVax-L) in glioblastoma: Breakthrough or fata morgana?
    Preusser, Matthias
    van den Bent, Martin J.
    NEURO-ONCOLOGY, 2023, 25 (04) : 631 - 634
  • [2] AUTOLOGOUS TUMOR LYSATE-LOADED DENDRITIC CELL VACCINATION IMPROVES SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA: SURVIVAL RESULTS FROM A PHASE 3 TRIAL
    Liau, Linda M.
    Ashkan, Keyoumars
    Brem, Steven
    Campian, Jian
    Trusheim, John
    Iwamoto, Fabio
    Tran, David
    Anstass, George
    Cobbs, Charles
    Heth, Jason
    Salacz, Michael
    D'Andre, Stacy
    Aiken, Robert
    Moshel, Yaron
    Nam, JooYeon
    Pillainayagam, Clement
    Wagner, Stephanie
    Walter, Kevin
    Chaudary, Rekha
    Goldlust, Samuel
    Lee, Ian
    Bota, Daniela
    Elinzano, Heinrich
    Grewal, Jai
    Lillehei, Kevin
    Mikkelsen, Tom
    Walbert, Tobias
    Abram, Steve
    Brenner, Andrew
    Ewend, Matthew
    Khagi, Simon
    Lovick, Darren
    Portnow, Jana
    Kim, Lyndon
    Loudon, William
    Martinez, Nina
    Thompson, Reid
    Avigan, David
    Fink, Karen
    Geoffroy, Francois
    Giglio, Pierre
    Gligich, Oleg
    Krex, Dietmar
    Lindhorst, Scott M.
    Lutzky, Jose
    Meisel, Hans-Joerg
    Nadji-Ohl, Minou
    Sanchin, Lhagva
    Sloan, Andrew
    Bosch, Marnix
    NEURO-ONCOLOGY, 2022, 24 : 66 - 66
  • [3] Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
    Shah, Siddharth
    Nag, Aiswarya
    Lucke-Wold, Brandon
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024,
  • [4] Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma A Phase 3 Prospective Externally Controlled Cohort Trial
    Liau, Linda M.
    Ashkan, Keyoumars
    Brem, Steven
    Campian, Jian L.
    Trusheim, John E.
    Iwamoto, Fabio M.
    Tran, David D.
    Ansstas, George
    Cobbs, Charles S.
    Heth, Jason A.
    Salacz, Michael E.
    D'Andre, Stacy
    Aiken, Robert D.
    Moshel, Yaron A.
    Nam, Joo Y.
    Pillainayagam, Clement P.
    Wagner, Stephanie A.
    Walter, Kevin A.
    Chaudary, Rekha
    Goldlust, Samuel A.
    Lee, Ian Y.
    Bota, Daniela A.
    Elinzano, Heinrich
    Grewal, Jai
    Lillehei, Kevin
    Mikkelsen, Tom
    Walbert, Tobias
    Abram, Steven
    Brenner, Andrew J.
    Ewend, Matthew G.
    Khagi, Simon
    Lovick, Darren S.
    Portnow, Jana
    Kim, Lyndon
    Loudon, William G.
    Martinez, Nina L.
    Thompson, Reid C.
    Avigan, David E.
    Fink, Karen L.
    Geoffroy, Francois J.
    Giglio, Pierre
    Gligich, Oleg
    Krex, Dietmar
    Lindhorst, Scott M.
    Lutzky, Jose
    Meisel, Hans-Jorg
    Nadji-Ohl, Minou
    Sanchin, Lhagva
    Sloan, Andrew
    Taylor, Lynne P.
    JAMA ONCOLOGY, 2023, 9 (01) : 112 - 121
  • [5] Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma: What happened to the evidence?
    Olivier, T.
    Migliorini, D.
    REVUE NEUROLOGIQUE, 2023, 179 (05) : 502 - 505
  • [6] Verlängerung des Gesamtüberlebens durch die Impfung von autologen tumorlysatbeladenen dendritischen Zellen (DCVax-L) bei Patienten mit neu diagnostiziertem und rezidivierendem GlioblastomAssociation of autologous tumor lysate-loaded dendritic cell vaccination with extension of survival among patients with newly diagnosed and recurrent glioblastoma
    Maximilian Y. Deng
    Jürgen Debus
    Laila König
    Strahlentherapie und Onkologie, 2023, 199 (3) : 327 - 329
  • [7] Nonrandomised controlled trial in recurrent glioblastoma patients: the promise of autologous tumour lysate-loaded dendritic cell vaccination
    Pasqualetti, Francesco
    Zanotti, Sofia
    BRITISH JOURNAL OF CANCER, 2023, 129 (06) : 895 - 896
  • [8] Nonrandomised controlled trial in recurrent glioblastoma patients: the promise of autologous tumour lysate-loaded dendritic cell vaccination
    Francesco Pasqualetti
    Sofia Zanotti
    British Journal of Cancer, 2023, 129 : 895 - 896
  • [9] A PHASE I TRIAL OF VACCINATION WITH AUTOLOGOUS DENDRITIC CELLS PULSED WITH LYSATE DERIVED FROM AN ALLOGENEIC GLIOBLASTOMA STEMLIKE CELL LINE FOR PATIENTS WITH NEWLY DIAGNOSED OR RECURRENT GLIOBLASTOMA
    Hu, Jethro
    Rudnick, Jeremy
    Wheeler, Christopher
    Mazer, Mia
    Wang, HongQiang
    Black, Keith
    Yu, John
    NEURO-ONCOLOGY, 2018, 20 : 4 - 4
  • [10] Treatment with tumor lysate-pulsed autologous dendritic cells prolongs survival in patients with recurrent glioblastoma multiforme
    Bosch, Marnix
    Prins, Robert
    Liau, Linda
    CANCER RESEARCH, 2015, 75
12345